The US Patent and Trademark Office (USPTO) has granted a patent to Vistagen’s non-opioid oral product candidate, AV-101 for ...

Naloxone is a fantastic tool in reducing opioid deaths, but gentler versions would be helpful for fighting overdose ...

Irritable bowel syndrome (IBS) is a common digestive disorder with unclear causes, affecting about 10% of the global population. Researchers have now discovered that opioid delta-receptor agonists may ...

University of Mississippi researchers have discovered how a compound found in cannabis might be used to mitigate the negative ...

Plus: A new non-opioid painkiller, the wave of lawsuits against Trump EOs, a key vote for RFK Jr., a big radiopharma deal and ...

Vistagen (VTGN) announced that the U.S. Patent and Trademark Office or USPTO, granted a patent to the company for its oral non-opioid product ...

Federal officials have approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S.

The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...

US President Donald Trump yesterday ordered 25% tariffs on Canadian and Mexican imports – lumping a 10% tax rate on goods from China as well saying Beijing needed to stanch the flow of fentanyl, a ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.